Article A randomized phase III trial of BIBW 2992 versus chemotherapy as first-line treatment for stage IIIB/IV adenocarcinoma of the lung harboring an epidermal growth factor receptor-activating mutation Author: Lecia V. Sequist, MD, MPH Chih-Hsin James Yang, MD Publish date: July 1, 2010 Read More
